PubMed:26808467 / 141-282
Annnotations
c_corpus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T31 | 13-20 | 6308 | denotes | leucine |
T32 | 13-20 | SO:0001437 | denotes | leucine |
T30 | 13-20 | CHEBI:15603 | denotes | leucine |
T33 | 13-20 | D007930 | denotes | leucine |
T34 | 13-20 | CHEBI:25017 | denotes | leucine |
T35 | 13-20 | D007930 | denotes | leucine |
T36 | 26-32 | SO:0001068 | denotes | repeat |
T37 | 43-48 | PR:Q5S006 | denotes | LRRK2 |
T38 | 43-48 | PR:000003033 | denotes | LRRK2 |
T39 | 43-48 | PR:Q5S007 | denotes | LRRK2 |
T40 | 80-90 | D000067562 | denotes | late onset |
T41 | 80-90 | D000067562 | denotes | late onset |
T42 | 91-109 | C566739 | denotes | autosomal dominant |
T45 | 118-135 | D010300 | denotes | Parkinson disease |
T46 | 118-135 | D010300 | denotes | Parkinson disease |
PubMed_ArguminSci
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-141 | DRI_Approach | denotes | Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common causes of late onset autosomal dominant form of Parkinson disease (PD). |